• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒的免疫特征:细胞因子风暴的深入原因及后果。

Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.

机构信息

Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland.

Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 71-455 Szczecin, Poland.

出版信息

Int J Mol Sci. 2022 Apr 20;23(9):4545. doi: 10.3390/ijms23094545.

DOI:10.3390/ijms23094545
PMID:35562935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9105989/
Abstract

In the beginning of the third year of the fight against COVID-19, the virus remains at least still one step ahead in the pandemic "war". The key reasons are evolving lineages and mutations, resulting in an increase of transmissibility and ability to evade immune system. However, from the immunologic point of view, the cytokine storm (CS) remains a poorly understood and difficult to combat culprit of the extended number of in-hospital admissions and deaths. It is not fully clear whether the cytokine release is a harmful result of suppression of the immune system or a positive reaction necessary to clear the virus. To develop methods of appropriate treatment and therefore decrease the mortality of the so-called COVID-19-CS, we need to look deeply inside its pathogenesis, which is the purpose of this review.

摘要

在抗击 COVID-19 的第三年伊始,该病毒在这场大流行“战争”中至少仍领先一步。关键原因是不断进化的谱系和突变,导致其传染性和逃避免疫系统能力增强。然而,从免疫学角度来看,细胞因子风暴(CS)仍然是导致住院人数和死亡人数增加的一个尚未完全了解且难以应对的罪魁祸首。目前尚不完全清楚细胞因子释放是免疫系统抑制的有害结果,还是清除病毒所必需的积极反应。为了开发适当的治疗方法,从而降低所谓 COVID-19-CS 的死亡率,我们需要深入研究其发病机制,这正是本次综述的目的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/074c39e0a793/ijms-23-04545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/bd01b7705ddb/ijms-23-04545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/ffeb88af2ca9/ijms-23-04545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/0ad4972e81a6/ijms-23-04545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/074c39e0a793/ijms-23-04545-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/bd01b7705ddb/ijms-23-04545-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/ffeb88af2ca9/ijms-23-04545-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/0ad4972e81a6/ijms-23-04545-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9479/9105989/074c39e0a793/ijms-23-04545-g004.jpg

相似文献

1
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.新冠病毒的免疫特征:细胞因子风暴的深入原因及后果。
Int J Mol Sci. 2022 Apr 20;23(9):4545. doi: 10.3390/ijms23094545.
2
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.细胞因子和趋化因子在严重急性呼吸综合征冠状病毒 2 感染中的作用。
Front Immunol. 2022 Apr 7;13:832394. doi: 10.3389/fimmu.2022.832394. eCollection 2022.
3
Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.新冠病毒肺炎患者细胞因子风暴及细胞因子靶向治疗的危害:综述
J Med Internet Res. 2020 Aug 13;22(8):e20193. doi: 10.2196/20193.
4
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.细胞因子风暴和白细胞变化在轻度和重度 SARS-CoV-2 感染中的表现:对中国 3939 例 COVID-19 患者的回顾,以及新出现的发病机制和治疗概念。
J Leukoc Biol. 2020 Jul;108(1):17-41. doi: 10.1002/JLB.3COVR0520-272R. Epub 2020 Jun 13.
5
A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.基于网络的分析揭示了维生素 D 抑制 SARS-CoV-2 感染中细胞因子风暴和病毒的机制。
Front Immunol. 2020 Dec 9;11:590459. doi: 10.3389/fimmu.2020.590459. eCollection 2020.
6
Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.细胞因子和趋化因子在 SARS-CoV-2 感染中的作用-靶向细胞因子风暴的治疗策略。
Biomolecules. 2021 Jan 12;11(1):91. doi: 10.3390/biom11010091.
7
Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate.严重的 COVID-19 是否为细胞因子风暴综合征:一场过度炎症的争论。
Curr Opin Rheumatol. 2021 Sep 1;33(5):419-430. doi: 10.1097/BOR.0000000000000822.
8
Cytokines and COVID-19: friends or foes?细胞因子与 COVID-19:是敌是友?
Hum Vaccin Immunother. 2020 Oct 2;16(10):2363-2365. doi: 10.1080/21645515.2020.1799669. Epub 2020 Aug 25.
9
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺,增加白细胞介素-1 水平,导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
10
Therapeutics for the Management of Cytokine Release Syndrome in COVID-19.新型冠状病毒肺炎细胞因子释放综合征的治疗管理
Curr Top Med Chem. 2023;23(2):128-142. doi: 10.2174/1568026622666220707114121.

引用本文的文献

1
Fu Tu Sheng Jin Rehabilitation Formula Mitigate Airway Inflammation, Mucus Secretion and Immune Dysfunction Induced by SARS-CoV-2 Spike Protein.伏菟生津康复方减轻SARS-CoV-2刺突蛋白诱导的气道炎症、黏液分泌和免疫功能障碍。
J Inflamm Res. 2025 Jan 22;18:1053-1065. doi: 10.2147/JIR.S480112. eCollection 2025.
2
Mesenchymal stromal cells (MSCs) as a therapeutic agent of inflammatory disease and infectious COVID-19 virus: live or dead mesenchymal?间充质基质细胞(MSCs)作为炎症性疾病和传染性新冠病毒的治疗剂:活的还是死的间充质细胞?
Mol Biol Rep. 2024 Feb 10;51(1):295. doi: 10.1007/s11033-023-09174-x.
3
Multidrug-resistant VAP before and during the COVID-19 pandemic among hospitalized patients in a tertiary private hospital.

本文引用的文献

1
Innate immunity: the first line of defense against SARS-CoV-2.先天免疫:抵御 SARS-CoV-2 的第一道防线。
Nat Immunol. 2022 Feb;23(2):165-176. doi: 10.1038/s41590-021-01091-0. Epub 2022 Feb 1.
2
Resolving the equation between mucormycosis and COVID-19 disease.解决毛霉病和 COVID-19 疾病之间的方程。
Mol Biol Rep. 2022 Apr;49(4):3349-3356. doi: 10.1007/s11033-021-07085-3. Epub 2022 Jan 22.
3
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.
一家私立三级医院中住院患者在新冠疫情之前及期间的耐多药呼吸机相关性肺炎情况
Antimicrob Steward Healthc Epidemiol. 2023 Oct 27;3(1):e192. doi: 10.1017/ash.2023.470. eCollection 2023.
4
Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review.与 COVID-19 感染及相关细胞因子风暴相关的表观遗传学观点:最新综述。
Infection. 2023 Dec;51(6):1603-1618. doi: 10.1007/s15010-023-02017-8. Epub 2023 Mar 12.
5
Immune responses in mildly versus critically ill COVID-19 patients.轻症与重症 COVID-19 患者的免疫反应。
Front Immunol. 2023 Jan 30;14:1077236. doi: 10.3389/fimmu.2023.1077236. eCollection 2023.
6
A Retrospective Assessment of Laboratory Findings and Cytokine Markers in Severe SARS-CoV-2 Infection among Patients of Roma Population.罗姆人群中重症新型冠状病毒2型感染患者实验室检查结果及细胞因子标志物的回顾性评估
J Clin Med. 2022 Nov 16;11(22):6777. doi: 10.3390/jcm11226777.
7
Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis.揭示 COVID-19 信息免疫学期刊传递的信息:文献计量学和可视化分析。
Front Immunol. 2022 Oct 31;13:1035151. doi: 10.3389/fimmu.2022.1035151. eCollection 2022.
8
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?从细胞因子风暴到细胞因子微风:免疫发病机制的经验教训是否改善了中重度新冠肺炎的免疫调节治疗?
Biomedicines. 2022 Oct 18;10(10):2620. doi: 10.3390/biomedicines10102620.
9
Dissecting Physiopathology of COVID-19.解析 COVID-19 的病理生理学。
Int J Mol Sci. 2022 Aug 24;23(17):9602. doi: 10.3390/ijms23179602.
10
COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong.2019冠状病毒病与磺脲类药物:在一类老牌药物即将退出历史舞台之际,对其多效性作用的一次提醒。
Metabolism. 2022 Aug;133:155221. doi: 10.1016/j.metabol.2022.155221. Epub 2022 May 26.
南非在 COVID-19 奥密克戎变异株流行期间住院患者的特征和结局与前几波相比。
JAMA. 2022 Feb 8;327(6):583-584. doi: 10.1001/jama.2021.24868.
4
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant.支持 SARS-CoV-2 奥密克戎变体源自鼠类的证据。
J Genet Genomics. 2021 Dec;48(12):1111-1121. doi: 10.1016/j.jgg.2021.12.003. Epub 2021 Dec 24.
5
Hematological changes associated with COVID-19 infection.与 COVID-19 感染相关的血液学变化。
J Clin Lab Anal. 2022 Jan;36(1):e24064. doi: 10.1002/jcla.24064. Epub 2021 Nov 16.
6
Understanding the prevalence of SARS-CoV-2 (COVID-19) exposure in companion, captive, wild, and farmed animals.了解 SARS-CoV-2(COVID-19)在伴侣动物、圈养动物、野生动物和养殖动物中的暴露流行情况。
Virulence. 2021 Dec;12(1):2777-2786. doi: 10.1080/21505594.2021.1996519.
7
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients.致病性T细胞和炎性单核细胞在重症COVID-19患者中引发炎症风暴。
Natl Sci Rev. 2020 Jun;7(6):998-1002. doi: 10.1093/nsr/nwaa041. Epub 2020 Mar 13.
8
The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients.褪黑素对 COVID-19 患者血栓、脓毒症和死亡率的影响。
Int J Infect Dis. 2022 Jan;114:79-84. doi: 10.1016/j.ijid.2021.10.012. Epub 2021 Oct 12.
9
IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant.白细胞介素 7 在 SARS-CoV-2 感染中的作用及其作为潜在疫苗佐剂的潜力。
Front Immunol. 2021 Sep 17;12:737406. doi: 10.3389/fimmu.2021.737406. eCollection 2021.
10
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic.无症状的新型冠状病毒感染比例。
Ann Intern Med. 2021 Sep;174(9):1344-1345. doi: 10.7326/L21-0491.